CILNIPAR M 5 MG/40 MG TABLET
Prescription Required
Introduction of Cilnipar M Tablet
CILNIPAR M 5 MG/40 MG TABLET is a medicine used to treat hypertension (high blood pressure). It is a combination of two medicines that effectively controls blood pressure when a single medication is not effective. By lowering the blood pressure, it helps in preventing future heart attack and stroke.
CILNIPAR M 5 MG/40 MG TABLET is a combination of two antihypertensive medicines
CILNIPAR M 5 MG/40 MG TABLET is a combination of two antihypertensive medicines
Uses of Cilnipar M Tablet
Benefits of Cilnipar M Tablet
In Hypertension (high blood pressure)
CILNIPAR M 5 MG/40 MG TABLET relaxes the blood vessels so that blood can flow more easily around your body. It also blocks the effects of some chemicals on your heart and blood vessels. This slows down your heart rate and helps the heart beat with less force. As a result, your blood pressure is lowered and this helps in reducing your risk of having a stroke, a heart attack, other heart problems, or kidney problems in the future. This medicine needs to be taken regularly to be effective, so keep taking it even if you feel well. Do not stop without talking to your doctor.
Side effects of Cilnipar M Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Cilnipar M
- Abnormal phosphorous level in blood
How to use Cilnipar M Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. CILNIPAR M 5 MG/40 MG TABLET is to be taken with food.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with CILNIPAR M 5 MG/40 MG TABLET.
Pregnancy
CONSULT YOUR DOCTOR
CILNIPAR M 5 MG/40 MG TABLET may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of CILNIPAR M 5 MG/40 MG TABLET during breastfeeding is not available. Please consult your doctor.
Driving
UNSAFE
CILNIPAR M 5 MG/40 MG TABLET may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of CILNIPAR M 5 MG/40 MG TABLET in patients with kidney disease. Please consult your doctor.
Liver
CAUTION
CILNIPAR M 5 MG/40 MG TABLET should be used with caution in patients with liver disease. Dose adjustment of CILNIPAR M 5 MG/40 MG TABLET may be needed. Please consult your doctor.
What if you forget to take Cilnipar M Tablet?
If you miss a dose of CILNIPAR M 5 MG/40 MG TABLET, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
Cilnipar M Tablet
- You have been prescribed CILNIPAR M 5 MG/40 MG TABLET for the treatment of high blood pressure.
- Lowering blood pressure reduces chance of future heart attack & strokes.
- It may cause dizziness. Get up slowly when rising from a sitting or lying position.
- Do not stop taking the medication suddenly without talking to your doctor as it can cause sudden increase in your blood pressure.
- Let your doctor know if you are pregnant or planning for pregnancy.
Fact Box
Habit Forming
No
Therapeutic Class
CARDIAC
Patient concerns
Patient concerns
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- PubChem. Cilnidipine. [Accessed 11 Apr. 2019] (online) Available from:
- Metoprolol succinate. Södertälje, Sweden: AstraZeneca AB; 1992 [revised 2010]. [Accessed 11 Apr. 2019] (online) Available from:
- Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 11 Apr. 2019] (online) Available from:
Marketer details
Name: Wockhardt Ltd
Address: Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Maharashtra, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
DISCONTINUED
We do not facilitate sale of this product at present